Chaiqin Chengqi Decoction as an adjuvant treatment for mild/moderately severe hypertriglyceridemic acute pancreatitis: A retrospective study

Table 2 Characteristics of the study population

Parameters	CQCQD	Control	P value
Number of patients	19	20
Number of male patients	15	15	1
Age (yr)	44.00 ± 13.24	41.25 ± 10.19	0.15
Hypertension (n)	2	5	0.41
Diabetes (n)	8	9	1
Fatty liver (n)	18	15	0.18
BMI (kg/m2)	28.87 ± 4.09	26.78 ± 4.38	0.43
NRS score	2.26 ± 0.28	1.68 ± 0.17	0.07
BISAP score	1.11 ± 0.17	0.65 ± 0.17	0.06
AGI score	1.00 ± 0.00	0.95 ± 0.05	0.32
Balthazar score	2.63 ± 0.22	2.37 ± 0.14	0.32
Biochemical data
WBC (× 109/L)	13.51 ± 1.16	12.21 ± 1.05	0.41
HCT	0.42 ± 0.01	0.42 ± 0.01	0.96
CRP (mg/L)	130.55 ± 19.98	58.42 ± 13.50	0.01a
AST (U/L)	29.37 ± 2.85	30.25 ± 5.29	0.87
ALT (U/L)	25.79 ± 4.11	34.40 ± ± 4.99	0.19
CHO (mmol/L)	9.76 ± 0.96	8.71 ± 0.56	0.34
TG (mmol/L)	14.93 ± 1.87	15.71 ± 1.72	0.78
APOE (mg/L)	163.26 ± 23.11	169.94 ± 14.52	0.81
UA (μmmol/L)	363.15 ± 31.70	383.28 ± 22.85	0.61

^aP < 0.05.

CQCQD: Chaiqin Chengqi Decoction; BMI: Body mass index; NRS: Numerical rating scale; BISAP: Bedside index for severity in acute pancreatitis; AGI: Acute gastrointestinal injury; WBC: White blood cell; HCT: Hematocrit; CRP: C-reactive protein; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; CHO: Cholesterol; TG: Triglyceride; APOE: Apolipoprotein E; UA: Uric acid.